Real life evaluation of sodium-glucose cotransporter 2 inhibition in type 1 diabetes and the risk of diabetic ketoacidosis.
Stougaard EB, Kristensen PL, Kielgast U, Andersen HU, Hamid Y, Gæde PH, Søndergaard E, Dørflinger GH, Fjeldborg KK, Hansen KW, Thomsen HH, Al-Imar TMJ, Røder M, Sridhar VS, Cherney D, Rossing P, Persson F.
Stougaard EB, et al.
Diab Vasc Dis Res. 2022 Sep-Oct;19(5):14791641221130043. doi: 10.1177/14791641221130043.
Diab Vasc Dis Res. 2022.
PMID: 36262089
Free PMC article.